Stephen B. Baylin
0000-0003-3697-3798
Publication & Citation Trends
Publications
1,260 total
Cell-free DNA fragmentomes for noninvasive detection of liver cirrhosis and other diseases.
Cited by 0
Semantic Scholar
Pembrolizumab and epigenetic modification with azacitidine reshapes the tumor microenvironment of platinum-resistant epithelial ovarian cancer: a phase 2 non-randomized clinical trial
Cited by 0
Semantic Scholar
Epigenetic Instability Based Metrics in Cell-Free DNA for Early Cancer Detection.
Cited by 0
Semantic Scholar
Genomic Landscapes of Endometrioid and Mucinous Ovarian Cancers and Morphologically Similar Tumor Types
Cited by 0
Semantic Scholar
Respiratory viral infections awaken metastatic breast cancer cells in lungs
Cited by 37
Semantic Scholar
Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy 2034
Cited by 0
Semantic Scholar
ZNFX1 functions as a master regulator of epigenetically induced pathogen mimicry and inflammasome signaling in cancer.
Cited by 3
Semantic Scholar
Dual EZH1/2 inhibition enhances DNMT inhibitor efficacy in colon cancer through targeting H3K27me1
Cited by 0
Semantic Scholar
Research Topics
Epigenetics and DNA Methylation
(581)
Cancer-related gene regulation
(185)
RNA modifications and cancer
(162)
Cancer Immunotherapy and Biomarkers
(153)
Cancer Genomics and Diagnostics
(144)
Affiliations
Broad Institute
Dartmouth College
Ontario Institute for Cancer Research
University of North Carolina at Chapel Hill
University of Southern California